Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service

BACKGROUND: The incidence of high-grade immune-related adverse events (irAEs) due to immune checkpoint inhibitors (ICIs) is increasing due to the rapid expansion of indications for their use. There is an urgent need for a feasible approach of identifying patients with high-grade irAEs to ensure earl...

Descripción completa

Detalles Bibliográficos
Autores principales: Abu-Shawer, Osama, Singh, Prabhsimranjot, Yenulevich, Eric, Brito, Amanda, Ni, Jian, Abdulnour, Raja-Elie E, Grover, Shilpa, Manos, Michael, Bowling, Peter, LeBoeuf, Nicole R, Ott, Patrick, Stephen Hodi, F, Jacobson, Joseph, Rahma, Osama
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437713/
https://www.ncbi.nlm.nih.gov/pubmed/32817360
http://dx.doi.org/10.1136/jitc-2020-000992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437713/
https://www.ncbi.nlm.nih.gov/pubmed/32817360
http://dx.doi.org/10.1136/jitc-2020-000992

Ejemplares similares